afamelanotide — Patent Landscape

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aggregated US Orange Book patent estate across every drug in the afamelanotide class. 1 active patents protecting 1 drugs. First major cliff: 2033. Daily refresh.

Drugs in class

Active US patents

62/100

Avg vulnerability

—

Annual revenue covered

Originators

Clivunel Inc 1 patents

Cliff calendar — next 15 years

Drugs ranked by patent estate

Drug	Originator	Active patents	Avg vuln	Revenue	First cliff
Scenesse AFAMELANOTIDE	Clivunel Inc	1	62	—	2033-01-20

Most attackable patents

Patent	Drug	Type	Vuln	Expiry
8334265	Scenesse	method of use	62	2033-01-20

Strongest defences

Patent	Drug	Type	Vuln	Expiry
8334265	Scenesse	method of use	62	2033-01-20

afamelanotide class hub (all drugs incl. pipeline)
AI Patent Landscape — type "afamelanotide" for an AI exec memo
Company Patent Rankings